M. Colle, J. Battin, J. P. Coquelin, and P. Rochiccioli, Betaxolol and propranolol in glucagon stimulation of growth hormone, Arch Dis Child, vol.59, pp.670-672, 1984.

J. R. Dillman, E. A. Smith, S. Khalatbari, and P. J. Strouse, I.v. glucagon use in Pediatric MR enterography: effect on image quality, length of examination, and patient tolerance, AJR Am J Roentgenol, vol.201, pp.185-189, 2013.

F. Bounoure, L. Skiba, M. Besnard, M. Arnaud, P. Mallet et al., Effect of iontophoresis and penetration enhancers on transdermal absorption of metopimazine, J Dermatol Sci, vol.52, pp.170-177, 2008.

J. Herrstedt, M. Jørgensen, and A. Hr, , 1990.

, The Authors, Pharmacology Research & Perspectives, 2015.

J. Herrstedt, J. Hyttel, and J. Pedersen, Interaction of the antiemetic metopimazine and anticancer agents with brain dopamine D2, 5-hydroxytryptamine3, histamine H1, muscarine cholinergic and a1-adrenaregic receptors, Cancer Chemother Pharmacol, vol.33, pp.53-56, 1993.

J. Herrstedt, M. Jørgensen, H. R. Angelo, M. R. Rassing, J. Møller-sonnergaard et al., Bioavailability of the antiemetic metopimazine given as a microenema, Br J Clin Pharmacol, vol.41, pp.613-615, 1996.

J. Herrstedt, T. Sigsgaard, H. R. Angelo, J. P. Kampmann, and M. Hansen, Dose-finding study of oral metopimazine, Support Care Cancer, vol.5, pp.38-43, 1997.

P. Jolliet, S. Nion, G. Allain-veyrac, L. Tilloy-fenart, D. Vanuxeem et al., Evidence of lowest brain penetration of an antiemetic drug, metopimazine, compared to domperidone, metoclopramide and chlorpromazine, using an in vitro model of the blood brain barrier, Pharmacol Res, vol.56, pp.11-17, 2007.
URL : https://hal.archives-ouvertes.fr/hal-00543519

, The Authors. Pharmacology Research & Perspectives published by John Wiley & Sons Ltd, vol.3, pp.130-137, 2015.